Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results

Rhythm Pharmaceuticals (RYTM) Misses Q1 EPS by 15c

May 14, 2018 8:11 AM EDT

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q1 EPS of ($0.60), $0.15 worse than the analyst estimate of ($0.45).

Our achievements year-to-date reflect our dual commitment to addressing the unmet medical needs of people living with rare genetic disorders of obesity and raising awareness and understanding of these conditions, said Keith Gottesdiener, M.D., Chief Executive Officer... More